THE ROLE OF HOMOEOPATHIC MEDICINES USING BOGER BOENNINGHAUSEN’S CHARACTERISTICS & REPERTORY IN HYPERURICEMIA AN OPEN LABEL PROSPECTIVE, CLINICAL STUDY
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Each enrolled case will be followed up monthly, with scores recorded at the time of patient
研究概览
简要总结
Hyperuricemia is a condition where there is an excess of uric acid in the blood. Uric acid is a waste product that is formed when the body breaks down purines, which are found in certain foods and drinks, as well as in the body’s cells. Normally, uric acid is excreted through urine, but when the body produces too much uric acid or fails to excrete enough, it can accumulate in the bloodstream. The primary test for hyperuricemia is a blood test that measures the level of uric acid in the blood. A serum uric acid level greater than 6.8 mg/dL is typically considered elevated and indicates hyperuricemia, though the exact threshold may vary slightly depending on the lab and individual factors. Homeopathic treatment for hyperuricemia aims to address the underlying imbalance in the body that leads to elevated uric acid levels. Homeopathy is a holistic approach that focuses on individualized case taking. medicines will be prescribed by using Boger Boenninghausen’s Characteristics of Repertory. Assessment will be (HUQoL) Hyperuricemia quality of life questionnaire score at base ,six month.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients with hyperuricemia either with or without active gout symptoms.
排除标准
- •Patient with high risk to lead kidney disease like nephropathy nephrolithiasis. Patients in need of surgical interventions & advanced cases with deformities will be excluded. Patients with known but controlled systemic diseases. Patient already undergoing homeopathic treatment of other chronic disease will be excluded. Pregnant and lactating mothers. Patients suffering from uncontrolled systemic illness any psychiatric illness or life.
- •threatening infections. Patient both male & female with more than 12 mg/dl Serum uric acid.
结局指标
主要结局
Each enrolled case will be followed up monthly, with scores recorded at the time of patient
时间窗: Each enrolled case will be followed up monthly, with scores recorded at the time of patient | entry (baseline), and the difference in serum uric acid levels will be assessed in 6 months.
entry (baseline), and the difference in serum uric acid levels will be assessed in 6 months
时间窗: Each enrolled case will be followed up monthly, with scores recorded at the time of patient | entry (baseline), and the difference in serum uric acid levels will be assessed in 6 months.
次要结局
- NOT APPLICABLE(NOT APPLICABLE)
研究者
SHIVAM KUMAR
National Institute of Homeopathy